Introduction: Gallic acid (GA) and curcumin (Cur) are natural phenolic compounds that their anti-tumor effects on many types of cancers have been proved. In the current study, the effect of the combination of these agents on MDA-MB-231 breast cancer cells was investigated. Methods: Inhibition of cell proliferation (MTT assay), light microscopy, fluorescence microscopy, cell cycle analysis, nitrite detection, ROS levels, measurement of the mitochondrial membrane potential, GSH level, Annexin V assay, RT-PCR and Western blotting methods were applied. Results: The results revealed the combination of GA and Cur strongly decreased MDA-MB-231 cell growth. Moreover, this combination increased ROS level and cytotoxic activity along with the glutath...
Abstract Background Curcumin, a natural compound derived from the turmeric rhizome Curcuma longa Lin...
Curcumin, a natural compound isolated from the Indian spice Haldi or curry powder , has been used...
Background Breast cancer is a collection of diseases in which molecular phenotypes can act as both i...
Breast cancer is a leading cancer in women and despite the benefits of the current therapies a signi...
Breast cancer is a leading cancer in women and despite the benefits of the current therapies a signi...
AbstractObjectiveCurcuminoids (including curcumin) are natural antioxidants demonstrating potent che...
Curcumin has been reported with an in vitro the cytotoxic effect on several human cancer cells. Howe...
Background: Breast cancer is the second leading cause of cancer-related death among females in the w...
AbstractThe aim of this study was to determine the mechanisms of curcumin-induced human breast cance...
OBJECTIVE: In many preclinical studies, curcumin has been anticarcinogenic in several cancer types. ...
Breast cancer is considered the most common cancer for women worldwide and it is now the second lead...
Introduction: Curcumin, a natural compound present in turmeric (Curcuma longa) has been known to pos...
Curcumin, an active constituent of turmeric, has been shown to possess inhibitory effect of cell pro...
In the current study, we sought to examine the effects of curcumin in a specific type of breast canc...
Curcumin has been shown to exert potential antitumor activity in vitro and in vivo involved in multi...
Abstract Background Curcumin, a natural compound derived from the turmeric rhizome Curcuma longa Lin...
Curcumin, a natural compound isolated from the Indian spice Haldi or curry powder , has been used...
Background Breast cancer is a collection of diseases in which molecular phenotypes can act as both i...
Breast cancer is a leading cancer in women and despite the benefits of the current therapies a signi...
Breast cancer is a leading cancer in women and despite the benefits of the current therapies a signi...
AbstractObjectiveCurcuminoids (including curcumin) are natural antioxidants demonstrating potent che...
Curcumin has been reported with an in vitro the cytotoxic effect on several human cancer cells. Howe...
Background: Breast cancer is the second leading cause of cancer-related death among females in the w...
AbstractThe aim of this study was to determine the mechanisms of curcumin-induced human breast cance...
OBJECTIVE: In many preclinical studies, curcumin has been anticarcinogenic in several cancer types. ...
Breast cancer is considered the most common cancer for women worldwide and it is now the second lead...
Introduction: Curcumin, a natural compound present in turmeric (Curcuma longa) has been known to pos...
Curcumin, an active constituent of turmeric, has been shown to possess inhibitory effect of cell pro...
In the current study, we sought to examine the effects of curcumin in a specific type of breast canc...
Curcumin has been shown to exert potential antitumor activity in vitro and in vivo involved in multi...
Abstract Background Curcumin, a natural compound derived from the turmeric rhizome Curcuma longa Lin...
Curcumin, a natural compound isolated from the Indian spice Haldi or curry powder , has been used...
Background Breast cancer is a collection of diseases in which molecular phenotypes can act as both i...